Cargando…
Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis
Muscular dystrophies are genetic diseases characterized by chronic inflammation and fibrosis. Macrophages are immune cells that sustain muscle regeneration upon acute injury but seem deleterious in the context of chronic muscle injury such as in muscular dystrophies. Here, we observed that the numbe...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322546/ https://www.ncbi.nlm.nih.gov/pubmed/35297529 http://dx.doi.org/10.1002/path.5895 |
_version_ | 1784756331588091904 |
---|---|
author | Saclier, Marielle Angelini, Giuseppe Bonfanti, Chiara Mura, Giada Temponi, Giulia Messina, Graziella |
author_facet | Saclier, Marielle Angelini, Giuseppe Bonfanti, Chiara Mura, Giada Temponi, Giulia Messina, Graziella |
author_sort | Saclier, Marielle |
collection | PubMed |
description | Muscular dystrophies are genetic diseases characterized by chronic inflammation and fibrosis. Macrophages are immune cells that sustain muscle regeneration upon acute injury but seem deleterious in the context of chronic muscle injury such as in muscular dystrophies. Here, we observed that the number of macrophages expressing the transcription factor Nfix increases in two distinct mouse models of muscular dystrophies. We showed that the deletion of Nfix in macrophages in dystrophic mice delays the establishment of fibrosis and muscle wasting, and increases grasp force. Macrophages lacking Nfix expressed more TNFα and less TGFβ1, thus promoting apoptosis of fibro‐adipogenic progenitors. Moreover, pharmacological treatment of dystrophic mice with a ROCK inhibitor accelerated fibrosis through the increase of Nfix expression by macrophages. Thus, we have identified Nfix as a macrophage profibrotic factor in muscular dystrophies, whose inhibition could be a therapeutic route to reduce severity of the dystrophic disease. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. |
format | Online Article Text |
id | pubmed-9322546 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-93225462022-07-30 Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis Saclier, Marielle Angelini, Giuseppe Bonfanti, Chiara Mura, Giada Temponi, Giulia Messina, Graziella J Pathol Original Articles Muscular dystrophies are genetic diseases characterized by chronic inflammation and fibrosis. Macrophages are immune cells that sustain muscle regeneration upon acute injury but seem deleterious in the context of chronic muscle injury such as in muscular dystrophies. Here, we observed that the number of macrophages expressing the transcription factor Nfix increases in two distinct mouse models of muscular dystrophies. We showed that the deletion of Nfix in macrophages in dystrophic mice delays the establishment of fibrosis and muscle wasting, and increases grasp force. Macrophages lacking Nfix expressed more TNFα and less TGFβ1, thus promoting apoptosis of fibro‐adipogenic progenitors. Moreover, pharmacological treatment of dystrophic mice with a ROCK inhibitor accelerated fibrosis through the increase of Nfix expression by macrophages. Thus, we have identified Nfix as a macrophage profibrotic factor in muscular dystrophies, whose inhibition could be a therapeutic route to reduce severity of the dystrophic disease. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. John Wiley & Sons, Ltd 2022-04-13 2022-07 /pmc/articles/PMC9322546/ /pubmed/35297529 http://dx.doi.org/10.1002/path.5895 Text en © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Saclier, Marielle Angelini, Giuseppe Bonfanti, Chiara Mura, Giada Temponi, Giulia Messina, Graziella Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis |
title | Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis |
title_full | Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis |
title_fullStr | Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis |
title_full_unstemmed | Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis |
title_short | Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis |
title_sort | selective ablation of nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322546/ https://www.ncbi.nlm.nih.gov/pubmed/35297529 http://dx.doi.org/10.1002/path.5895 |
work_keys_str_mv | AT sacliermarielle selectiveablationofnfixinmacrophagesattenuatesmusculardystrophybyinhibitingfibroadipogenicprogenitordependentfibrosis AT angelinigiuseppe selectiveablationofnfixinmacrophagesattenuatesmusculardystrophybyinhibitingfibroadipogenicprogenitordependentfibrosis AT bonfantichiara selectiveablationofnfixinmacrophagesattenuatesmusculardystrophybyinhibitingfibroadipogenicprogenitordependentfibrosis AT muragiada selectiveablationofnfixinmacrophagesattenuatesmusculardystrophybyinhibitingfibroadipogenicprogenitordependentfibrosis AT temponigiulia selectiveablationofnfixinmacrophagesattenuatesmusculardystrophybyinhibitingfibroadipogenicprogenitordependentfibrosis AT messinagraziella selectiveablationofnfixinmacrophagesattenuatesmusculardystrophybyinhibitingfibroadipogenicprogenitordependentfibrosis |